ESC 365
Menu
Home
Search
Live & Upcoming Events
About
Create an account
Sign in
Back
ESC Premium Access
Meet the Experts - Safety first: avoiding adverse events with new cardiovascular drugs
Event:
ESC Congress 2018
Topic:
Cardiovascular Pharmacotherapy
Session type:
Expert Session
Date:
26 August 2018
Time:
11:00 - 12:30
Congress Session
1
6
presentations
in this session
Safety first: avoiding adverse events with new cardiovascular drugs - Panel
Access
0
Introduction - Safety first: avoiding adverse events with new cardiovascular drugs
Speaker:
Doctor M. Alonso Garcia (London, GB)
Access
Slides
Video
0
Scenario 1 - Adverse events of new lipid lowering drugs.
Speaker:
Doctor T. Hall (Oslo, NO)
Access
Slides
Video
0
Scenario 2 - Neprilysin inhibitors in heart failure: safety and adverse events
Speaker:
Assistant Professor M. Kaluzna-Oleksy (Poznan, PL)
Access
Slides
0
Scenario 3 - Long-term safety of new anti-diabetic drugs.
Speaker:
Associate Professor A. Niessner (Vienna, AT)
Access
Slides
Video
0
Safety first: avoiding adverse events with new cardiovascular drugs - Take Home Message.
Speaker:
Professor J. Tamargo (Madrid, ES)
Access
Slides
Video
0
5
speakers
from this session
Doctor Maria Angeles Alonso Garcia
Imperial College London, London (United Kingdom of Great Britain & Northern Ireland)
2
presentations
0
follower
Doctor Trygve Sundby Hall
Oslo University Hospital Ulleval, Oslo (Norway)
4
presentations
0
follower
Assistant Professor Marta Izabela Kaluzna-Oleksy
Poznan University of Medical Sciences, Poznan (Poland)
4
presentations
0
follower
Associate Professor Alexander Niessner
Medical University of Vienna, Vienna (Austria)
6
presentations
0
follower
Professor Juan Luis Tamargo
Complutense University of Madrid, Madrid (Spain)
8
presentations
2
followers
This platform is supported by